Kristy Ainslie, Ph.D. applies her knowledge base in biomaterials, and immunology to develop new immune-modulatory therapies that treat and prevent infectious, and autoimmune diseases. Her lab aims to design practical and innovative formulations, taking into account the scalable production and applications in developing nations.

Drug Formulation, Electrospray, Electrospun Scaffolds, Polymer Synthesis   Bacterial resistance, Diabetes, Drug Delivery, Immunomodulation, Immunotherapy, Inflammation, Nanomedicine, Nanoparticle, Vaccines